|1||Not yet recruiting||
ICG and Blue Dye Guided Sentinel Lymph Node Biopsy in Patients Underwent Neoadjuvant Therapy
|2||Active, not recruiting||
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)
Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer
† Study has passed its completion date and status has not been verified in more than two years.